Company profile for Molecular Templates

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Molecular Templates is developing ETBs, protein-based therapeutics with a novel mechanism of action (the enzymatic destruction of ribosomes), predictable PK and ADME, and turn-key GMP manufacturing. Molecular Templates can move quickly from concept to clinic. Antibodies to targets of interest can be quickly (~8 weeks) screened in an ETB format to select leads based on forced internalization, specificity, and potency. ETBs are ...
Molecular Templates is developing ETBs, protein-based therapeutics with a novel mechanism of action (the enzymatic destruction of ribosomes), predictable PK and ADME, and turn-key GMP manufacturing. Molecular Templates can move quickly from concept to clinic. Antibodies to targets of interest can be quickly (~8 weeks) screened in an ETB format to select leads based on forced internalization, specificity, and potency. ETBs are generally consistent in their PK and ADME profiles and in their manufacturing process.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Corporate Headquarters 9301 Amberglen Blvd Suite 100 Austin, TX 78729
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2024/12/19/3000258/0/en/Molecular-Templates-Announces-Notice-of-Delisting-and-Failure-to-Satisfy-Continued-Listing-Rules.html

GLOBENEWSWIRE
19 Dec 2024

https://www.globenewswire.com/news-release/2024/12/02/2990188/0/en/Molecular-Templates-Announces-Receipt-of-Expected-Notification-of-Deficiency-from-Nasdaq-Related-to-Delayed-filing-of-Quarterly-Report-on-Form-10-Q-and-Failure-to-Meet-Bid-Price-Re.html

GLOBENEWSWIRE
02 Dec 2024

https://www.globenewswire.com/news-release/2024/08/14/2930510/0/en/Molecular-Templates-Inc-Reports-Second-Quarter-2024-Financial-Results-and-Corporate-Update.html

GLOBENEWSWIRE
14 Aug 2024

https://www.globenewswire.com/news-release/2024/06/03/2892230/0/en/Molecular-Templates-Inc-Provides-Interim-Update.html

GLOBENEWSWIRE
03 Jun 2024

https://www.globenewswire.com/news-release/2024/05/15/2882982/0/en/Molecular-Templates-Inc-Reports-First-Quarter-2024-Financial-Results-and-Corporate-Update.html

GLOBENEWSWIRE
15 May 2024

https://www.globenewswire.com/news-release/2024/04/09/2859974/0/en/Molecular-Templates-Presents-Interim-Data-from-MT-6402-Phase-I-Study-in-Patients-with-PD-L1-Solid-Tumors-at-the-2024-American-Association-for-Cancer-Research-AACR-Annual-Meeting-Mo.html

GLOBENEWSWIRE
09 Apr 2024

ABOUT THIS PAGE

Contact Molecular Templates and get a quotation

Molecular Templates is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of SN33962 bulk with DMF offered by Molecular Templates

Find a price of SN35006 bulk with DMF offered by Molecular Templates

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty